Magazine
Sign up for your free subscription and keep up-to-date.
Upcoming Events
Newsletters
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
Biotechnology Focus
May 2006 ~ Volume 9 Issue 5
|
May 04 2006
ASKED & ANSWERED Compiled by Amber Lepage-Monette International patents, World Trade Organization (WTO) (Geneva, Switzerland) regulations, the Doha Declaration on Trade Related Aspects of Intellectual Property Rights (TRIPs) Agreement, and WTO members' right to protect public health and, in particular, to promote access to medicines for all.
|
|
May 04 2006
Immune Response By Kristine Archer VIDO is giving vaccine research a real shot in the arm
When most Canadians think of Saskatchewan, they might picture prairie winds and wheat fields. But there's more to this province than farmers and livestock. The Vaccine and Infectious Disease Organization (VIDO), located in Saskatoon, Sask., has become a leading international research centre, dedicated to developing vaccines for all manner of diseases. While their accomplishments are clear and their future is bright, VIDO has come a long way from where it started. |
|
May 04 2006
Crossing the Chasm to a Sustainable Biopharmaceutical Industry By Anthony J. Giovinazzo The case for a biomedical merchant bank
Should Canada have a sustainable biopharmaceutical industry? Can it become a biotech nation, or does it lack the critical mass to reach the scale needed to do so? |
|
May 04 2006
Follow Your Instincts By Amber Lepage-Monette When it comes to making key business decisions, MethylGene Inc. (Montreal, QC) has had more than a few "light bulb" moments over the last 10 years. It's knowing when to follow through on those bright ideas that has served the company so well.
|
Biotechnology Focus: Corporate Profiles
|
May 04 2006
LymphoSign Inc.Envisioning a Cure By Stephen McDonald Supplied By president and CEO Dr. Joseph Elliot, PhD
With revolutionary targeted therapeutics, LymphoSign has its sights set firmly on the treatment of cancer. |
|
May 04 2006
IBEX Technologies Inc. Extending Life through Biomarker Research By Stephen McDonald Supplied By president and CEO Paul Baehr
Montreal-based IBEX Technologies Inc. (TSX: IBT) is a biopharmaceutical company specializing in disease-related biomolecules to develop therapeutics and diagnostics for the management of cancer and arthritis. |